NewsBenzingaKeybanc Initiates Coverage On NeuroPace with Overweight Rating, Announces Price Target of $18 Keybanc Initiates Coverage On NeuroPace with Overweight Rating, Announces Price Target of $18 Benzinga 2026.09.18 10:38 (GMT+0) Open on Benzinga Other news What to Expect From Advanced Micro Devices’ Q3 2026 Earnings Report Here's What to Expect From Uber’s Next Earnings Report Aflac’s Q3 2026 Earnings: What to Expect Marathon Petroleum Earnings Preview: What to Expect American International Group’s Quarterly Earnings Preview: What You Need to Know Meta removes language that raised scraping and AI training concerns
